|
GB877732A
(en)
|
1958-08-12 |
1961-09-20 |
Lepetit Spa |
The antibiotic rifomycin, its components and methods of preparing same
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4610919A
(en)
|
1985-06-14 |
1986-09-09 |
Fiber Bond Corporation |
Binder for fibrous padding
|
|
JP2544375B2
(ja)
|
1986-07-14 |
1996-10-16 |
鐘淵化学工業株式会社 |
アルキル置換ベンゾキサジノリフアマイシン誘導体
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
CA1304363C
(en)
|
1988-11-01 |
1992-06-30 |
Takehiko Yamane |
3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
ATE255131T1
(de)
|
1991-06-14 |
2003-12-15 |
Genentech Inc |
Humanisierter heregulin antikörper
|
|
US5362852A
(en)
|
1991-09-27 |
1994-11-08 |
Pfizer Inc. |
Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
|
|
US5545721A
(en)
|
1992-12-21 |
1996-08-13 |
Ophidian Pharmaceuticals, Inc. |
Conjugates for the prevention and treatment of sepsis
|
|
US6660267B1
(en)
|
1992-12-21 |
2003-12-09 |
Promega Corporation |
Prevention and treatment of sepsis
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US6214388B1
(en)
|
1994-11-09 |
2001-04-10 |
The Regents Of The University Of California |
Immunoliposomes that optimize internalization into target cells
|
|
US5981522A
(en)
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
JP3963976B2
(ja)
|
1995-12-08 |
2007-08-22 |
株式会社カネカ |
クラミジア感染症治療剤
|
|
US6322788B1
(en)
|
1998-08-20 |
2001-11-27 |
Stanley Arthur Kim |
Anti-bacterial antibodies and methods of use
|
|
PT1176195E
(pt)
|
1999-04-09 |
2013-07-18 |
Kyowa Hakko Kirin Co Ltd |
Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
|
|
US7101692B2
(en)
*
|
1999-04-15 |
2006-09-05 |
The Regents Of The University Of California |
Identification of sortase gene
|
|
CA2373221A1
(en)
|
1999-05-03 |
2000-11-30 |
Yashwant M. Deo |
Human antibodies to staphylococcus aureus
|
|
CA2388245C
(en)
|
1999-10-19 |
2012-01-10 |
Kyowa Kirin Co., Ltd. |
The use of serum-free adapted rat cells for producing heterologous polypeptides
|
|
US7064191B2
(en)
|
2000-10-06 |
2006-06-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Process for purifying antibody
|
|
DK2314686T4
(da)
|
2000-10-06 |
2023-08-21 |
Kyowa Kirin Co Ltd |
Celler, der danner antistofsammensætninger
|
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
WO2003002885A1
(en)
*
|
2001-06-28 |
2003-01-09 |
Freni Brembo S.P.A. |
Composite disc for a disc brake having a splittable braking band
|
|
WO2003026577A2
(en)
|
2001-09-24 |
2003-04-03 |
Seattle Genetics, Inc. |
P-amidobenzylethers in drug delivery agents
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
KR100988949B1
(ko)
|
2001-10-25 |
2010-10-20 |
제넨테크, 인크. |
당단백질 조성물
|
|
JP2005511627A
(ja)
|
2001-11-20 |
2005-04-28 |
シアトル ジェネティクス，インコーポレーテッド |
抗ｃｄ３０抗体を使用する免疫学的疾患の治療
|
|
JP2005510534A
(ja)
*
|
2001-11-21 |
2005-04-21 |
アクティブバイオティクス インコーポレイティッド |
標的化治療薬およびその使用
|
|
US20040093621A1
(en)
|
2001-12-25 |
2004-05-13 |
Kyowa Hakko Kogyo Co., Ltd |
Antibody composition which specifically binds to CD20
|
|
US20040110704A1
(en)
|
2002-04-09 |
2004-06-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells of which genome is modified
|
|
AU2003236020B2
(en)
|
2002-04-09 |
2009-03-19 |
Kyowa Hakko Kirin Co., Ltd. |
Cell with depression or deletion of the activity of protein participating in GDP-fucose transport
|
|
US20040259150A1
(en)
|
2002-04-09 |
2004-12-23 |
Kyowa Hakko Kogyo Co., Ltd. |
Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
|
|
AU2003236017B2
(en)
|
2002-04-09 |
2009-03-26 |
Kyowa Kirin Co., Ltd. |
Drug containing antibody composition
|
|
EP1502603A4
(en)
|
2002-04-09 |
2006-12-13 |
Kyowa Hakko Kogyo Kk |
AN ANTIBODY COMPOSITION CONTAINING MEDICAMENT FOR PATIENTS WITH Fc gamma RIIIa POLYMORPHISM
|
|
CA2481837A1
(en)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Production process for antibody composition
|
|
EP1575514A2
(en)
|
2002-07-31 |
2005-09-21 |
Seattle Genetics, Inc. |
Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders
|
|
ES2544527T3
(es)
|
2002-07-31 |
2015-09-01 |
Seattle Genetics, Inc. |
Conjugados de fármacos y su uso para tratar el cáncer, una enfermedad autoinmune o una enfermedad infecciosa
|
|
US7217797B2
(en)
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
CA2502413A1
(en)
|
2002-11-01 |
2004-05-21 |
The Regents Of The University Of Colorado, A Body Corporate |
Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry
|
|
EP1944320A1
(en)
|
2002-12-16 |
2008-07-16 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
EP1663107A4
(en)
|
2003-08-22 |
2010-06-23 |
Activbiotics Pharma Llc |
RIFAMYCIN ANALOGS AND USES THEREOF
|
|
AU2004279742A1
(en)
|
2003-10-08 |
2005-04-21 |
Kyowa Hakko Kirin Co., Ltd. |
Fused protein composition
|
|
JPWO2005035778A1
(ja)
|
2003-10-09 |
2006-12-21 |
協和醗酵工業株式会社 |
α１，６−フコシルトランスフェラーゼの機能を抑制するＲＮＡを用いた抗体組成物の製造法
|
|
EP3434275A1
(en)
*
|
2003-11-06 |
2019-01-30 |
Seattle Genetics, Inc. |
Assay for cancer cells based on the use of auristatin conjugates with antibodies
|
|
JPWO2005053742A1
(ja)
|
2003-12-04 |
2007-06-28 |
協和醗酵工業株式会社 |
抗体組成物を含有する医薬
|
|
WO2005062882A2
(en)
|
2003-12-23 |
2005-07-14 |
Activbiotics, Inc |
Rifamycin analogs and uses thereof
|
|
EP1718667B1
(en)
*
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|
|
WO2007008848A2
(en)
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
JP5171621B2
(ja)
|
2005-07-07 |
2013-03-27 |
シアトル ジェネティックス， インコーポレイテッド |
フェニルアラニン側鎖修飾をｃ末端に有するモノメチルバリン化合物
|
|
EP1928890B1
(en)
*
|
2005-08-11 |
2013-04-03 |
Targanta Therapeutics Inc. |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
CN101395259A
(zh)
|
2005-12-14 |
2009-03-25 |
活跃生物药物学有限公司 |
利福霉素类似物及其应用
|
|
TW200902554A
(en)
|
2007-05-08 |
2009-01-16 |
Genentech Inc |
Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates
|
|
AU2008312457B2
(en)
|
2007-10-19 |
2014-04-17 |
Genentech, Inc. |
Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
|
|
AU2009246510B2
(en)
|
2008-05-12 |
2014-02-13 |
Strox Biopharmaceuticals, Llc |
Staphylococcus aureus-specific antibody preparations
|
|
US8524691B2
(en)
|
2008-08-13 |
2013-09-03 |
The Medicines Company |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
WO2010042481A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial eap, emp, and/or adsa proteins
|
|
US8916193B2
(en)
*
|
2008-12-10 |
2014-12-23 |
Cipla Limited |
Rifaximin complexes
|
|
TR201809128T4
(tr)
*
|
2009-07-15 |
2018-07-23 |
Aimm Therapeutics Bv |
Gram-pozitif bakterilere spesifik bağlanan bileşikler.
|
|
ES2531471T3
(es)
|
2011-02-25 |
2015-03-16 |
Lonza Ltd |
Enlazador ramificado para conjugados de proteínas-fármacos
|
|
AU2012395148B2
(en)
*
|
2012-11-24 |
2016-10-27 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
MA38686A1
(fr)
|
2013-05-31 |
2017-10-31 |
Genentech Inc |
Anticorps anti-acide téichoïque de la paroi cellulaire et conjugués associés
|
|
BR112015029754A2
(pt)
*
|
2013-05-31 |
2017-09-26 |
Genentech Inc |
anticorpos anti-teicoico da parede e conjugados
|
|
KR102337414B1
(ko)
*
|
2013-12-16 |
2021-12-10 |
제넨테크, 인크. |
펩타이드 모방체 화합물 및 이의 항체-약물 컨쥬게이트
|
|
UA118113C2
(uk)
*
|
2013-12-16 |
2018-11-26 |
Дженентек, Інк. |
Пептидоміметичні сполуки та їх кон'югати антитіла з лікарським засобом
|